Okta, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Okta, Inc. trades at $136.54 (market cap $24.63B), while Zimmer Biomet Holdings Inc trades at $88.69 (market cap $17.20B). The key difference: Okta, Inc. is the larger of the two by market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Okta, Inc. pays none. Which is the better fit depends on your goals.
| OKTA | ZBH | |
|---|---|---|
Market Cap | $24.63B | $17.20B |
Sector | Technology | Health |
52-Week High | $154.62 | $107.71 |
52-Week Low | $62.93 | $79.58 |
Enterprise Value | $22.45B | $24.25B |
Dividend Yield | — | 1.08% |
Trailing returns across standard periods
Latest headlines on both assets
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →